ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Coya Therapeutics Inc

Coya Therapeutics Inc (COYA)

6,88
0,59
(9,38%)
Fermé 09 Mars 10:00PM
7,4999
0,6199
(9,01%)
Après les heures de négociation: 11:06PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
7,4999
Prix Achat
6,70
Prix Vente
7,50
Volume échangé
629 628
6,1624 Fourchette du Jour 7,38
4,75 Plage de 52 semaines 10,6899
Cap du marché
Clôture Veille
6,29
Ouverture
6,22
Dernière Transaction
3
@
7.5
Dernière heure de transaction
Volume financier
US$ 4 425 904
VWAP
7,0294
Volume moyen (3 m)
85 022
Actions en circulation
16 707 441
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,29
Bénéfice par action (BPA)
-0,48
Chiffre d'affairess
6M
Bénéfice net
-7,99M

À propos de Coya Therapeutics Inc

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-de... Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a low-dose interleukin 2 Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Coya Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker COYA. Le dernier cours de clôture d'Coya Therapeutics était de US$6,29. Au cours de la dernière année, les actions de Coya Therapeutics ont été négociées dans une fourchette de prix de US$ 4,75 à US$ 10,6899.

Coya Therapeutics compte actuellement 16 707 441 actions en circulation. La capitalisation boursière d'Coya Therapeutics est de US$105,09 million. Coya Therapeutics a un ratio cours/bénéfice (ratio PE) de -14.29.

COYA Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.839912.61111111116.668.296.27321315987.04086638CS
40.40995.781382228497.098.295.8051213136.59770248CS
121.619927.54931972795.888.295.07850226.29095213CS
261.419923.35361842116.0810.245.07844796.83053894CS
52-1.9801-20.88713080179.4810.68994.75747427.4134386CS
1562.749957.89263157894.7510.68993.21699026.44775771CS
2602.749957.89263157894.7510.68993.21699026.44775771CS

COYA - Frequently Asked Questions (FAQ)

What is the current Coya Therapeutics share price?
The current share price of Coya Therapeutics is US$ 7,4999
How many Coya Therapeutics shares are in issue?
Coya Therapeutics has 16 707 441 shares in issue
What is the market cap of Coya Therapeutics?
The market capitalisation of Coya Therapeutics is USD 105,09M
What is the 1 year trading range for Coya Therapeutics share price?
Coya Therapeutics has traded in the range of US$ 4,75 to US$ 10,6899 during the past year
What is the PE ratio of Coya Therapeutics?
The price to earnings ratio of Coya Therapeutics is -14,29
What is the cash to sales ratio of Coya Therapeutics?
The cash to sales ratio of Coya Therapeutics is 19,01
What is the reporting currency for Coya Therapeutics?
Coya Therapeutics reports financial results in USD
What is the latest annual turnover for Coya Therapeutics?
The latest annual turnover of Coya Therapeutics is USD 6M
What is the latest annual profit for Coya Therapeutics?
The latest annual profit of Coya Therapeutics is USD -7,99M
What is the registered address of Coya Therapeutics?
The registered address for Coya Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Coya Therapeutics website address?
The website address for Coya Therapeutics is www.coyatherapeutics.com
Which industry sector does Coya Therapeutics operate in?
Coya Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock